IMNM
Price
$7.92
Change
-$0.64 (-7.48%)
Updated
May 21 closing price
Capitalization
689.14M
83 days until earnings call
KYTX
Price
$2.21
Change
-$0.18 (-7.53%)
Updated
May 21 closing price
Capitalization
95.51M
Interact to see
Advertisement

IMNM vs KYTX

Header iconIMNM vs KYTX Comparison
Open Charts IMNM vs KYTXBanner chart's image
Immunome
Price$7.92
Change-$0.64 (-7.48%)
Volume$917.92K
Capitalization689.14M
Kyverna Therapeutics
Price$2.21
Change-$0.18 (-7.53%)
Volume$510.21K
Capitalization95.51M
IMNM vs KYTX Comparison Chart
Loading...
IMNM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
KYTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
IMNM vs. KYTX commentary
May 22, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IMNM is a Buy and KYTX is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
May 22, 2025
Stock price -- (IMNM: $7.92 vs. KYTX: $2.21)
Brand notoriety: IMNM and KYTX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: IMNM: 73% vs. KYTX: 171%
Market capitalization -- IMNM: $689.14M vs. KYTX: $95.51M
IMNM [@Biotechnology] is valued at $689.14M. KYTX’s [@Biotechnology] market capitalization is $95.51M. The market cap for tickers in the [@Biotechnology] industry ranges from $305.18B to $0. The average market capitalization across the [@Biotechnology] industry is $2.24B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IMNM’s FA Score shows that 0 FA rating(s) are green whileKYTX’s FA Score has 0 green FA rating(s).

  • IMNM’s FA Score: 0 green, 5 red.
  • KYTX’s FA Score: 0 green, 5 red.
According to our system of comparison, IMNM is a better buy in the long-term than KYTX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IMNM’s TA Score shows that 7 TA indicator(s) are bullish while KYTX’s TA Score has 5 bullish TA indicator(s).

  • IMNM’s TA Score: 7 bullish, 3 bearish.
  • KYTX’s TA Score: 5 bullish, 1 bearish.
According to our system of comparison, IMNM is a better buy in the short-term than KYTX.

Price Growth

IMNM (@Biotechnology) experienced а -0.63% price change this week, while KYTX (@Biotechnology) price change was +2.79% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +6.07%. For the same industry, the average monthly price growth was +10.40%, and the average quarterly price growth was -0.77%.

Reported Earning Dates

IMNM is expected to report earnings on Aug 13, 2025.

KYTX is expected to report earnings on May 14, 2025.

Industries' Descriptions

@Biotechnology (+6.07% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
IMNM($689M) has a higher market cap than KYTX($95.5M). IMNM YTD gains are higher at: -25.424 vs. KYTX (-40.909). KYTX (-108.46M) and IMNM (-109.95M) have comparable annual earnings (EBITDA) . KYTX has more cash in the bank: 322M vs. IMNM (240M). IMNM has less debt than KYTX: IMNM (2.72M) vs KYTX (9.14M). IMNM has higher revenues than KYTX: IMNM (10.1M) vs KYTX (0).
IMNMKYTXIMNM / KYTX
Capitalization689M95.5M721%
EBITDA-109.95M-108.46M101%
Gain YTD-25.424-40.90962%
P/E RatioN/AN/A-
Revenue10.1M0-
Total Cash240M322M75%
Total Debt2.72M9.14M30%
TECHNICAL ANALYSIS
Technical Analysis
IMNMKYTX
RSI
ODDS (%)
Bearish Trend 1 day ago
75%
N/A
Stochastic
ODDS (%)
Bearish Trend 1 day ago
87%
Bullish Trend 1 day ago
86%
Momentum
ODDS (%)
Bullish Trend 1 day ago
90%
Bullish Trend 1 day ago
70%
MACD
ODDS (%)
Bullish Trend 1 day ago
80%
N/A
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
87%
Bullish Trend 1 day ago
70%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
87%
Bullish Trend 1 day ago
68%
Advances
ODDS (%)
Bullish Trend 6 days ago
81%
Bullish Trend 6 days ago
78%
Declines
ODDS (%)
Bearish Trend 15 days ago
87%
Bearish Trend 16 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
90%
N/A
Aroon
ODDS (%)
Bullish Trend 1 day ago
89%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
IMNM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
KYTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
HISVX37.94N/A
N/A
Harbor Small Cap Value Investor
LEISX22.32N/A
N/A
Federated Hermes Equity Income IS
JSJAX15.36N/A
N/A
JHancock Small Cap Dynamic Growth A
LYFAX12.04N/A
N/A
AlphaCentric Life Sciences & Hlthcare A
GLFOX17.78-0.07
-0.39%
Lazard Global Listed Infrastructure Open

IMNM and

Correlation & Price change

A.I.dvisor indicates that over the last year, IMNM has been loosely correlated with IDYA. These tickers have moved in lockstep 59% of the time. This A.I.-generated data suggests there is some statistical probability that if IMNM jumps, then IDYA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IMNM
1D Price
Change %
IMNM100%
-7.48%
IDYA - IMNM
59%
Loosely correlated
-2.45%
KYMR - IMNM
56%
Loosely correlated
-4.17%
BEAM - IMNM
55%
Loosely correlated
-2.99%
RXRX - IMNM
55%
Loosely correlated
-10.00%
SYRE - IMNM
53%
Loosely correlated
-4.03%
More

KYTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, KYTX has been loosely correlated with CABA. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if KYTX jumps, then CABA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KYTX
1D Price
Change %
KYTX100%
-7.53%
CABA - KYTX
46%
Loosely correlated
-4.52%
IMNM - KYTX
46%
Loosely correlated
-7.48%
CRSP - KYTX
45%
Loosely correlated
-5.76%
TRDA - KYTX
42%
Loosely correlated
-6.67%
PRME - KYTX
42%
Loosely correlated
-0.85%
More